BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer. Int J Mol Sci 2019;20:E2870. [PMID: 31212809 DOI: 10.3390/ijms20122870] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Bure IV, Nemtsova MV. Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected. Int J Mol Sci 2021;22:5683. [PMID: 34073603 DOI: 10.3390/ijms22115683] [Reference Citation Analysis]
2 Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, Yu H, Chen K, Hu Q, Xia X, Liu S, Guan W. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. Clin Transl Med 2021;11:e522. [PMID: 34459127 DOI: 10.1002/ctm2.522] [Reference Citation Analysis]
3 Gu H, Zhong Y, Liu J, Shen Q, Wei R, Zhu H, Zhang X, Xia X, Yao M, Ni M. The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis. Front Oncol 2022;11:793678. [DOI: 10.3389/fonc.2021.793678] [Reference Citation Analysis]
4 Tan L, Qu W, Wu D, Liu M, Ai Q, Hu H, Wang Q, Chen W, Zhou H. The interferon regulatory factor 6 promotes cisplatin sensitivity in colorectal cancer. Bioengineered 2022;13:10504-17. [PMID: 35443865 DOI: 10.1080/21655979.2022.2062103] [Reference Citation Analysis]
5 Schmidt U, Heller G, Timelthaler G, Heffeter P, Somodi Z, Schweifer N, Sibilia M, Berger W, Csiszar A. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness. J Exp Clin Cancer Res 2021;40:69. [PMID: 33596971 DOI: 10.1186/s13046-021-01862-5] [Reference Citation Analysis]
6 Kumar P, Sebastian A, Verma K, Dixit R, Kumari S, Singh J, Tiwary SK, Narayan G. mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study. Indian J Surg Oncol 2021;12:85-92. [PMID: 33994733 DOI: 10.1007/s13193-020-01096-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rossi T, Tedaldi G, Petracci E, Abou Khouzam R, Ranzani GN, Morgagni P, Saragoni L, Monti M, Calistri D, Ulivi P, Molinari C. E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer. Int J Mol Sci 2019;20:E4452. [PMID: 31509966 DOI: 10.3390/ijms20184452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Lv DD, Zhou LY, Tang H. Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment. Exp Mol Med 2021;53:8-18. [PMID: 33462379 DOI: 10.1038/s12276-020-00551-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dzobo K, Senthebane DA, Ganz C, Thomford NE, Wonkam A, Dandara C. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Cells 2020;9:E1896. [PMID: 32823711 DOI: 10.3390/cells9081896] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
10 Song C, Zhou C. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis. J Exp Clin Cancer Res 2021;40:62. [PMID: 33563300 DOI: 10.1186/s13046-021-01859-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Xu Z, Ran J, Gong K, Hou Y, Li J, Guo Y. LncRNA SUMO1P3 regulates the invasion, migration and cell cycle of gastric cancer cells through Wnt/β-catenin signaling pathway. Journal of Receptors and Signal Transduction. [DOI: 10.1080/10799893.2020.1836494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hu Y, Hu Z, Liao T, Li Y, Pan Y. LncRNA SND1-IT1 facilitates TGF-β1-induced epithelial-to-mesenchymal transition via miR-124/COL4A1 axis in gastric cancer. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-021-00793-6] [Reference Citation Analysis]
13 Zhou L, Lu H, Zeng F, Zhou Q, Li S, Wu Y, Yuan Y, Xin L. Constructing a new prognostic signature of gastric cancer based on multiple data sets. Bioengineered 2021;12:2820-35. [PMID: 34157940 DOI: 10.1080/21655979.2021.1940030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Otake S, Itoh Y, Omata C, Saitoh M, Miyazawa K. ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus-dependent E-cadherin downregulation. Cancer Sci 2021;112:205-16. [PMID: 33068045 DOI: 10.1111/cas.14701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Torres K, Landeros N, Wichmann IA, Polakovicova I, Aguayo F, Corvalan AH. EBV miR-BARTs and human lncRNAs: Shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer. Biochim Biophys Acta Mol Basis Dis 2021;1867:166049. [PMID: 33401001 DOI: 10.1016/j.bbadis.2020.166049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
17 Song X, Tan L, Wang M, Ren C, Guo C, Yang B, Ren Y, Cao Z, Li Y, Pei J. Myricetin: A review of the most recent research. Biomed Pharmacother 2021;134:111017. [PMID: 33338751 DOI: 10.1016/j.biopha.2020.111017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
18 Yu Y, Li H, Wu C, Li J. Circ_0021087 acts as a miR-184 sponge and represses gastric cancer progression by adsorbing miR-184 and elevating FOSB expression. Eur J Clin Invest 2021;:e13605. [PMID: 34076278 DOI: 10.1111/eci.13605] [Reference Citation Analysis]
19 Posch F, Prinz F, Balihodzic A, Mayr C, Kiesslich T, Klec C, Jonas K, Barth DA, Riedl JM, Gerger A, Pichler M. MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms. Cancers (Basel) 2021;13:3996. [PMID: 34439151 DOI: 10.3390/cancers13163996] [Reference Citation Analysis]
20 Feng C, Liu S, Shang Z. Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes. Front Cell Dev Biol 2022;9:798898. [DOI: 10.3389/fcell.2021.798898] [Reference Citation Analysis]
21 Hu X, Wang Z, Wang Q, Chen K, Han Q, Bai S, Du J, Chen W. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering. Biomed Pharmacother 2021;144:112222. [PMID: 34607103 DOI: 10.1016/j.biopha.2021.112222] [Reference Citation Analysis]
22 Guo P, Tian Z, Kong X, Yang L, Shan X, Dong B, Ding X, Jing X, Jiang C, Jiang N, Yu Y. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J Exp Clin Cancer Res. 2020;39:202. [PMID: 32993749 DOI: 10.1186/s13046-020-01677-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
23 Ma Y, Zhang P, Zhang Q, Wang X, Miao Q, Lyu X, Cui B, Ma H. Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer. Oncol Lett 2021;22:688. [PMID: 34457043 DOI: 10.3892/ol.2021.12949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Eryi S, Zheng L, Honghua C, Su Z, Han X, Donggang P, Zhou Z, Liping Z, Bo C, Wang J. HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-β/Smad Signaling Pathway and Predicts a Poor Prognosis in Glioblastoma. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/8016102] [Reference Citation Analysis]
25 Wu D, Zhu J, Fu Y, Li C, Wu B. LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis. Cancer Biomark 2021;30:203-12. [PMID: 33104019 DOI: 10.3233/CBM-190913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Wang JM, Li X, Yang P, Geng WB, Wang XY. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. BMC Gastroenterol 2022;22:76. [PMID: 35189810 DOI: 10.1186/s12876-022-02159-3] [Reference Citation Analysis]
27 Stone TW. Dependence and Guidance Receptors-DCC and Neogenin-In Partial EMT and the Actions of Serine Proteases. Front Oncol 2020;10:94. [PMID: 32117748 DOI: 10.3389/fonc.2020.00094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Chen G, Liao J, Xu Y, Chen Y, Li J, Bu G, Li Q. LINC01232 Promotes Metastasis and EMT by Regulating miR-506-5p/PAK1 Axis in Gastric Cancer. CMAR 2022;Volume 14:1729-40. [DOI: 10.2147/cmar.s352081] [Reference Citation Analysis]
29 Zhou D, He Y, Li H, Huang W. Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition. Exp Ther Med 2021;22:770. [PMID: 34055069 DOI: 10.3892/etm.2021.10202] [Reference Citation Analysis]
30 Li S, Zhao W, Sun M. An Analysis Regarding the Association Between the ISLR Gene and Gastric Carcinogenesis. Front Genet 2020;11:620. [PMID: 32612640 DOI: 10.3389/fgene.2020.00620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Wang HL, Zhao XK, Zhou FY, Song X, Li LY, Huang GR, Bao QD, Lei LL, Yang HJ, Li L, Xu RH, Li AL, Wang XZ, Han WL, Ren JL, Wang LD. Characterization of E-cadherin expression in normal mucosa, dysplasia and adenocarcinoma of gastric cardia and its influence on prognosis. World J Gastrointest Oncol 2022; 14(1): 265-277 [DOI: 10.4251/wjgo.v14.i1.265] [Reference Citation Analysis]